ERBB2 and breast carcinoma: As the expression did not correlate with either patients’ age, tumour stage, nodal stage or hormonal receptor status and Her-2/Neu status, hsa-miR-652-5p may be widely applicable as a possible blood-based biomarker for breast cancer detection.